Post Tagged with: "inhibitor"

NIH Supports Goetz Team to Study Novel Therapeutic

Model of Tideglusib bound to a kinase (GSK3) associated with medical disorders such as Alzheimer's disease and cancer (image courtesy of J. V. Hines).

By Amanda Biederman NQPI editorial intern Douglas Goetz, Chemical and Biomolecular Engineering Professor, Molecular and Cellular Biology Faculty and Nanoscale & Quantum Phenomena Institute member, and Ohio University colleagues were recently awarded a grant from the National Institutes of Health to characterize an inhibitor of glycogen synthase kinase 3 (GSK3), […]

Read more ›
May 14, 2017 at 9:14 pmNews